Study guide
5.3 Meconium Aspiration & PPHN
NBRC RRT-NPS Neonatal/Pediatric Specialist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neonatal and Pediatric Patient Assessment
1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage
2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring
2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics
3 Chapter 3: Airway Management & Secretion Clearance
3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning
4 Chapter 4: Pharmacology & Medical Gas Therapy
4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation
5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders
5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration
6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety
6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care
7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation
7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk
8 Chapter 8: High-Frequency Ventilation & Advanced Modes
8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure
9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy
9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response
10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness
10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains
11 Chapter 11: Congenital Heart Disease & Hemodynamic Management
11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS
12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care
12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation
5.3 Meconium Aspiration & PPHN
Key Takeaways Explain This Topic AI
Meconium aspiration can combine airway obstruction, chemical pneumonitis, surfactant dysfunction, pulmonary hypertension, and air leak; severity and complications vary widely.
Current neonatal resuscitation guidance does not recommend routine tracheal suction solely for a nonvigorous infant born through meconium. Perform standard initial steps, clear the airway only when obstruction impedes breathing or ventilation, and provide effective PPV promptly when the infant is apneic, gasping, or remains below 100/min.
Secondary PPHN requires lung recruitment, correction of hypoxemia and acidosis, echocardiographic assessment, and selective pulmonary vasodilation when indicated. A persistently high OI supports early ECMO-center consultation but never orders cannulation by itself.
Last updated: September 2026
5.3 Meconium Aspiration & PPHN
Meconium aspiration is an acute neonatal airway, parenchymal, and pulmonary-vascular disorder seen mainly in term and post-term infants. Management depends on obstruction, lung recruitment, gas exchange, air leak, and associated persistent pulmonary hypertension of the newborn (PPHN).
Meconium Aspiration Syndrome (MAS)
Meconium is the thick, dark-green viscous fecal matter produced in the fetal intestinal tract, composed of water (85–95%), desquamated gastrointestinal epithelial cells, intestinal secretions, bile pigments (bilirubin), bile acids, cholesterol, pancreatic enzymes, and swallowed amniotic fluid constituents (lanugo, vernix caseosa).
Pathogenesis of Meconium Passage and Aspiration
Meconium passage in utero occurs almost exclusively in term ( ≥ 37 weeks \ge 37\text{ weeks} ≥ 37 weeks ) and post-term ( ≥ 42 weeks \ge 42\text{ weeks} ≥ 42 weeks ) fetuses, occurring in 10% to 15% of all deliveries. It is exceptionally rare in preterms < 34 weeks <34\text{ weeks} < 34 weeks due to the absence of mature gastrointestinal neural innervation and low circulating concentrations of motilin.
Intrauterine Asphyxia & Vagal Activation: Acute or chronic uteroplacental insufficiency, umbilical cord compression, or prolonged labor leads to fetal hypoxia and acidemia. Hypoxia triggers mesenteric vasoconstriction, hyperperistalsis, and relaxation of the fetal anal sphincter, discharging meconium into the surrounding amniotic fluid.
Gasping Respirations In Utero: Under severe asphyxia, fetal chemoreceptors stimulate deep, uncoordinated gasping respiratory efforts before delivery. Meconium-contaminated fluid is drawn past the vocal cords and deep into the distal tracheobronchial tree. +-------------------------------------------------------------------------------------------------------------+
| THE FOUR PATHOLOGICAL MECHANISMS OF MAS |
+-------------------------------------+-----------------------------------------------------------------------+
- | 1. Complete Airway Obstruction | Thick, particulate meconium completely blocks small airways, |
- | | preventing ventilation. Trapped distal alveolar gas is resorbed, |
- | | causing regional absorption atelectasis and true right-to-left shunt. |
+-------------------------------------+-----------------------------------------------------------------------+
- | 2. Partial Airway Obstruction | Viscous plugs create a one-way 'ball-valve' mechanism: airway dilates |
- | ('Ball-Valve' Air Trapping) | on inspiration, admitting air, but narrows on expiration, trapping |
- | | air. Causes dynamic hyperinflation and pneumothorax (10-20% risk). |
+-------------------------------------+-----------------------------------------------------------------------+
- | 3. Chemical Pneumonitis | Bile salts, acids, and enzymes trigger intense inflammatory response |
- | & Surfactant Inactivation | (TNF-alpha, IL-1beta, IL-6), leading to hemorrhagic alveolar edema. |
- | | Free fatty acids competitively displace and degrade surfactant. |
+-------------------------------------+-----------------------------------------------------------------------+
- | 4. Persistent Pulmonary | Chronic fetal hypoxia induces medial muscular hypertrophy of small |
- | Hypertension (PPHN) | pulmonary arteries. Severe postnatal vasoconstriction elevates PVR, |
- | | producing right-to-left ductal/foramen shunting and refractory hypoxia.|
+-------------------------------------+-----------------------------------------------------------------------+
Clinical Presentation & Radiography
Physical Exam: Typically an overgrown, post-term infant displaying evidence of chronic dysmaturity (peeling, parchment-like skin, absence of vernix, wasted subcutaneous fat). Yellow-green meconium staining is evident on the skin, umbilical cord, and fingernails (staining of the cord implies meconium exposure > 1 to 2 hours >1\text{ to }2\text{ hours} > 1 to 2 hours ; nail staining implies > 6 hours >6\text{ hours} > 6 hours ). Immediately following delivery, the infant exhibits severe respiratory distress: prominent tachypnea, deep intercostal/subcostal retractions, nasal flaring, grunting, and a barrel-shaped chest from dynamic air trapping. Auscultation reveals widespread coarse rales, rhonchi, and expiratory wheezes.
Chest Radiograph Findings:
Asymmetric, Coarse, Fluffy Infiltrates: 'Rope-like' or streaky parenchymal opacities scattered throughout both lung fields.
Areas of Hyperlucency: Alternating with consolidative patches, reflecting regional air trapping.
Marked Hyperinflation: Depressed, flattened diaphragmatic domes (diaphragms pushed below the 9th or 10th posterior ribs).
Pulmonary Air Leak: High incidence of pneumothorax or pneumomediastinum.
Current NRP Resuscitation Guidelines: The Paradigm Shift
For decades, clinical practice mandated immediate direct laryngoscopy and endotracheal suctioning using a meconium aspirator for any non-vigorous infant born through meconium before providing positive pressure breaths.
Critical Exam Rule: Routine Suctioning is Obsolete
Current Neonatal Resuscitation Program guidance, including the 9th edition, does not recommend routine endotracheal suctioning solely because a non-vigorous infant was born through meconium-stained fluid.
Multiple multicenter randomized controlled trials demonstrated that routine intubation does not reduce the incidence of MAS or mortality, and direct laryngoscopy dangerously delays the initiation of positive pressure ventilation (PPV) in depressed neonates.
Current NRP Protocol:
At delivery, regardless of whether the infant is vigorous or non-vigorous, bring the infant to the radiant warmer.
Perform initial steps: provide warmth, position head and neck to open airway, clear secretions from the mouth and nose using a bulb syringe or suction catheter only if secretions are visibly obstructing the airway or positive pressure breaths are impeded .
Dry and stimulate the infant.
If the infant is apneic, gasping, or exhibits a heart rate < 100 bpm <100\text{ bpm} < 100 bpm , initiate Positive Pressure Ventilation (PPV) immediately using a T-piece resuscitator or bag-mask with room air ( 21 % O 2 21\%\text{ }\text{O}_2 21% O 2 ) within the first 60 seconds of life ('The Golden Minute').
Reserve endotracheal intubation solely for indications where PPV is ineffective, or when airway obstruction persists despite repositioning and suctioning.
Critical Care Management of MAS in the NICU
Ventilator Strategies: Ventilating lungs with heterogeneously obstructed airways carries immense risk of barotrauma and air leak. Target a lung-protective approach :
Sufficient PEEP ( 5 to 7 cmH 2 O 5\text{ to }7\text{ cmH}_2\text{O} 5 to 7 cmH 2 O ) to stabilize non-obstructed, atelectatic units.
Moderate tidal volumes ( 4 to 6 mL/kg 4\text{ to }6\text{ mL/kg} 4 to 6 mL/kg ) to prevent overdistension of hyperinflated segments.
Adequate Expiratory Time ( T E T_E T E ): Use a rate and inspiratory time that provide adequate expiratory time, then verify expiratory flow returns toward baseline and measure total PEEP. Exact settings depend on age, resistance, compliance, spontaneous effort, and gas exchange.
High-Frequency Oscillatory Ventilation (HFOV): Preferred when high peak pressures ( > 28 to 30 cmH 2 O >28\text{ to }30\text{ cmH}_2\text{O} > 28 to 30 cmH 2 O ) fail to achieve adequate ventilation or when air leak syndromes (pneumothorax) supervene.
Exogenous Surfactant Replacement: Secondary surfactant inactivation by meconium fatty acids contributes significantly to alveolar collapse. Administering exogenous surfactant (e.g., Poractant alfa) replaces inactivated stores and significantly reduces the need for ECMO.
Management of Secondary PPHN:
Target pre-ductal SpO 2 \text{SpO}_2 SpO 2 between 92 % and 97 % 92\%\text{ and }97\% 92% and 97% ; avoid severe hypoxia or extreme hyperoxia.
Inhaled Nitric Oxide (iNO): For a term or near-term infant over 34 weeks with hypoxic respiratory failure and clinical or echocardiographic pulmonary hypertension, the labeled dose is 20 ppm 20\text{ ppm} 20 ppm with ventilatory and disease-specific therapy. OI supports severity assessment but is not a labeled eligibility cutoff.
Extracorporeal Membrane Oxygenation (ECMO): For severe potentially reversible MAS/PPHN despite optimized rescue therapy, consult an ECMO center early. A persistent OI around or above 40 is a traditional high-risk trigger for urgent evaluation, not an automatic cannulation rule.
Worked Calculation: The Oxygenation Index (OI)
The Oxygenation Index (OI) is an important serial severity metric in neonatal hypoxemic respiratory failure. It supports escalation decisions but does not by itself determine iNO use or ECMO eligibility: OI = Mean Airway Pressure (MAP, in cmH 2 O ) × FiO 2 × 100 PaO 2 (in mmHg) \text{OI} = \frac{\text{Mean Airway Pressure (MAP, in cmH}_2\text{O}) \times \text{FiO}_2 \times 100}{\text{PaO}_2\text{ (in mmHg)}} OI = PaO 2 (in mmHg) Mean Airway Pressure (MAP, in cmH 2 O ) × FiO 2 × 100
Worked Case Example
A 41-week infant weighing 3 , 800 g 3,800\text{ g} 3 , 800 g with severe Meconium Aspiration Syndrome and echocardiogram-confirmed PPHN is ventilated in the NICU on pressure-controlled ventilation. The ventilator graphics display a Mean Airway Pressure (MAP) of 18 cmH 2 O 18\text{ cmH}_2\text{O} 18 cmH 2 O while receiving an FiO 2 of 1.0 \text{FiO}_2\text{ of }1.0 FiO 2 of 1.0 ( 100 % O 2 100\%\text{ }\text{O}_2 100% O 2 ).
An arterial blood gas obtained from a pre-ductal right radial arterial line reveals:
- pH 7.23 \text{pH } 7.23 pH 7.23
- PaCO 2 54 mmHg \text{PaCO}_2\ 54\text{ mmHg} PaCO 2 54 mmHg
- PaO 2 42 mmHg \text{PaO}_2\ 42\text{ mmHg} PaO 2 42 mmHg
- HCO 3 − 22 mEq/L \text{HCO}_3^-\ 22\text{ mEq/L} HCO 3 − 22 mEq/L
Calculate the Oxygenation Index: OI = 18 × 1.0 × 100 42 = 1800 42 ≈ 42.9 \text{OI} = \frac{18 \times 1.0 \times 100}{42} = \frac{1800}{42} \approx 42.9 OI = 42 18 × 1.0 × 100 = 42 1800 ≈ 42.9
Clinical Interpretation & Action Ladder:
A rising OI signals worsening oxygenation relative to applied mean airway pressure and should trigger reassessment of airway, lung volume, hemodynamics, diagnosis, and rescue strategy.
For labeled-age neonatal hypoxic respiratory failure with pulmonary-hypertension physiology, consider a monitored iNO trial at the recommended 20 ppm dose under the neonatal protocol; OI is contextual rather than a fixed indication.
A persistent OI around or above 40 is a traditional marker of severe refractory failure. Trigger urgent ECMO-center consultation and candidacy evaluation; OI alone does not predict one mortality percentage or mandate cannulation.
- NPS Exam Traps
- Exam Trap 1: Tracheal Suctioning in Non-Vigorous Meconium Delivery
If an exam vignette describes a term infant born limp, cyanotic, and apneic through thick meconium, candidates often instinctively choose endotracheal intubation and direct suctioning before any other action. This is an outdated failure. Current NRP guidelines dictate: place on warmer, clear secretions with a bulb syringe only if obstructing the airway, dry, stimulate, and begin Positive Pressure Ventilation (PPV) immediately. Do not delay PPV to intubate for meconium clearance.